Zalavras C G, Rigopoulos N, Poultsides L, Patzakis M J
Department of Orthopaedics, LAC+USC Medical Center, University of Southern California, Keck School of Medicine, 1200 N. State St. GNH-3900, Los Angeles, CA 90033, USA.
Clin Orthop Relat Res. 2008 Jun;466(6):1405-9. doi: 10.1007/s11999-008-0198-3. Epub 2008 Mar 8.
Thigh abscesses due to pyomyositis are uncommon. To guide empiric antibiotic therapy in diabetics we determined the rate of such infections due to oxacillin-resistant Staphylococcus aureus and Gram-negative organism infections, and whether the occurrence of oxacillin-resistant pathogens increased during the study period. We retrospectively reviewed 39 adult patients with diabetes mellitus treated for a deep thigh abscess. There were 29 men and 10 women; their mean age was 45 years. Comorbidities were present in 15 patients. S. aureus was the most common pathogen, present in 82% (32/39) of our patients. Gram-negative organisms were cultured in 14% (6/39) of patients and anaerobes in 10% (4/39). The infection was polymicrobial in 12 of 39 patients (31%). Oxacillin-resistant S. aureus comprised 25% (8/32) of infections due to S. aureus. Oxacillin-resistance increased during the last 3 years of this study from one of 18 S. aureus isolates from 1994 to 2004 to seven of 14 isolates from 2004 to 2006. In diabetic patients with thigh pyomyositis, empiric antibiotic therapy should provide broad spectrum coverage for oxacillin-resistant S. aureus, Gram-negative, as well as anaerobic organisms.
Level IV, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.
因脓性肌炎导致的大腿脓肿并不常见。为指导糖尿病患者的经验性抗生素治疗,我们确定了耐苯唑西林金黄色葡萄球菌和革兰氏阴性菌感染导致此类感染的发生率,以及在研究期间耐苯唑西林病原体的发生率是否增加。我们回顾性分析了39例因大腿深部脓肿接受治疗的成年糖尿病患者。其中男性29例,女性10例;平均年龄45岁。15例患者存在合并症。金黄色葡萄球菌是最常见的病原体,在我们的患者中占82%(32/39)。14%(6/39)的患者培养出革兰氏阴性菌,10%(4/39)培养出厌氧菌。39例患者中有12例(31%)感染为多微生物感染。耐苯唑西林金黄色葡萄球菌占金黄色葡萄球菌所致感染的25%(8/32)。在本研究的最后3年中,耐苯唑西林率从1994年至2004年18株金黄色葡萄球菌分离株中的1株增加到2004年至2006年14株分离株中的7株。对于患有大腿脓性肌炎的糖尿病患者,经验性抗生素治疗应提供针对耐苯唑西林金黄色葡萄球菌、革兰氏阴性菌以及厌氧菌的广谱覆盖。
IV级,诊断性研究。有关证据水平的完整描述,请参阅作者指南。